Log in
Log in
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Sign up
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
  1. Homepage
  2. Equities
  3. Sweden
  4. Nasdaq Stockholm
  5. BICO Group AB (publ)
  6. Company
    BICO   SE0013647385

BICO GROUP AB (PUBL)

(BICO)
  Report
Delayed Nasdaq Stockholm  -  11:29 2022-12-02 am EST
77.06 SEK   -1.46%
11/14Notice of extraordinary general meeting in BICO Group AB (publ)
AQ
11/10Transcript : BICO Group AB - Analyst/Investor Day
CI
11/10BICO Group announces new financial targets
AQ
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisionsFunds 
Business Summary
Logo BICO Group AB (publ)
Cellink AB is a Sweden-based company, which is primarily involved in the healthcare industry. The Company focuses on the application areas of bioprinting, multiomics, cell line development, and diagnostics. The Company develops and markets technologies that enable researchers in the life sciences to culture cells in 3D, perform high-throughput drug screening and print human tissues and organs for the medical, pharmaceutical, and cosmetic industries. The CompanyÔÇÖs operations divided in two segments: The Industrial Solutions segment that offers products within precision dispensing and biosensor technology for industrial customers, which make a high-capacity contribution to customers production; and The Laboratory Solutions segment that offers 3Dprinters, single- cell and liquid- dispensing instruments as well as services and consumables related to these products.

Number of employees : 1 159 people.
Sales per Business
20202021Delta
Laboratory197.8863.4%741.3059% +274.63%
Bioautomation114.1336.6%516.0041% +352.11%
SEK in Million
Sales per region
20202021Delta
North America143.3445.9%641.1051% +347.26%
Europe--383.3030.5%-
Asia61.9419.9%160.5012.8% +159.12%
Rest of the World10.343.3%72.405.8% +600.43%
Sweden8.712.8%---
SEK in Million
Managers
Name Title Age Since
Erik Paul Gatenholm President, Chief Executive Officer & Director 32 2016
Mikael Engblom Chief Financial Officer 44 2022
Hector Daniel Martinez Avila, Dr. Chief Technology Officer & Executive VP 36 2016
┼sa Hillsten Senior Vice President & Head-Investor Relations - -
Artur Aira Manager-Business Area Bioprinting 54 2020
Jonas Schoendube, Dr. Manager-Business Area Biosciences 36 2020
Holger Eickhoff, Dr. Manager-Business Area Industrial Solutions 56 2020
Tommy Niklasson Vice President-Finance - -
Lotta Bus Senior Vice President & General Counsel 51 2020
Karin Danielsson Director-Global Human Resources 39 2018
Members of the board
Name Title Age Since
Carsten Nils Erik Browall Chairman 63 2019
Bengt Sj÷holm Independent Director 68 2016
Helena Margareta Skňntorp Independent Director 61 2019
Christian Wildmoser, Dr. Independent Director 67 2019
Ulrika Dellby Independent Director 55 2022
Rolf Classon Independent Director 76 -
Erik Paul Gatenholm President, Chief Executive Officer & Director 32 2016
Susan H. Tousi Director 52 2021
Equities
Vote QuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 62,586,269 43,767,563 69.9% 0 0.0% 68.3%
Stock B 1 1,500,000 0 0.0% 0 0.0%
Shareholders
NameEquities%
Erik Paul Gatenholm 8,767,036 14.0%
Handelsbanken Fonder AB 6,413,977 10.2%
Hector Daniel Martinez Avila 5,751,284 9.19%
Capital Research & Management Co. (World Investors) 3,006,516 4.80%
Swedbank Robur Fonder AB 2,379,484 3.80%
Fjńrde AP-fonden 1,964,314 3.14%
ARK Investment Management LLC 1,297,756 2.07%
Carl Reinhold Adolf Bennet 1,181,000 1.89%
Joh. Berenberg, Gossler & Co. KG (Investment Management) 1,119,819 1.79%
Gusten Danielsson 1,117,232 1.79%
Company contact information
BICO Group AB
Arvid Wallgrens Backe 20
Gothenburg, Vastra Gotaland 413 46

Phone : +46.31.12.87.00
Web : http://bico.com
Brand Portfolio
In partnership withAllbrands.markets
More brands of BICO Group AB (publ)
Sector Other Advanced Medical Equipment & Technology